Switch theme
Sign up to access all valuation multiples
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
1943
14.1K+
LTM Revenue $3.1B
LTM EBITDA $888M
$7.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Teleflex has a last 12-month revenue (LTM) of $3.1B and a last 12-month EBITDA of $888M.
In the most recent fiscal year, Teleflex achieved revenue of $3.0B and an EBITDA of $434M.
Teleflex expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Teleflex valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | XXX | $3.0B | XXX | XXX | XXX |
| Gross Profit | $1.8B | XXX | $1.7B | XXX | XXX | XXX |
| Gross Margin | 60% | XXX | 56% | XXX | XXX | XXX |
| EBITDA | $888M | XXX | $434M | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 14% | XXX | XXX | XXX |
| EBIT | $804M | XXX | $546M | XXX | XXX | XXX |
| EBIT Margin | 26% | XXX | 18% | XXX | XXX | XXX |
| Net Profit | $635M | XXX | $69.7M | XXX | XXX | XXX |
| Net Margin | 21% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.4B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Teleflex's stock price is $122.
Teleflex has current market cap of $5.4B, and EV of $7.1B.
See Teleflex trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7.1B | $5.4B | XXX | XXX | XXX | XXX | $13.74 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Teleflex has market cap of $5.4B and EV of $7.1B.
Teleflex's trades at 2.3x EV/Revenue multiple, and 16.4x EV/EBITDA.
Equity research analysts estimate Teleflex's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Teleflex has a P/E ratio of 8.5x.
See valuation multiples for Teleflex and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5.4B | XXX | $5.4B | XXX | XXX | XXX |
| EV (current) | $7.1B | XXX | $7.1B | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.3x | XXX | XXX | XXX |
| EV/EBITDA | 8.0x | XXX | 16.4x | XXX | XXX | XXX |
| EV/EBIT | 8.9x | XXX | 13.1x | XXX | XXX | XXX |
| EV/Gross Profit | 3.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 8.5x | XXX | 77.5x | XXX | XXX | XXX |
| EV/FCF | 15.7x | XXX | 14.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTeleflex's last 12 month revenue growth is 3%
Teleflex's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Teleflex's rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Teleflex's rule of X is 36% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Teleflex and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | -2% | XXX | 6% | XXX | XXX | XXX |
| Rule of 40 | 28% | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 36% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 38% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Teleflex acquired XXX companies to date.
Last acquisition by Teleflex was XXXXXXXX, XXXXX XXXXX XXXXXX . Teleflex acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Teleflex founded? | Teleflex was founded in 1943. |
| Where is Teleflex headquartered? | Teleflex is headquartered in United States of America. |
| How many employees does Teleflex have? | As of today, Teleflex has 14.1K+ employees. |
| Who is the CEO of Teleflex? | Teleflex's CEO is Mr. Liam J. Kelly. |
| Is Teleflex publicy listed? | Yes, Teleflex is a public company listed on NYS. |
| What is the stock symbol of Teleflex? | Teleflex trades under TFX ticker. |
| When did Teleflex go public? | Teleflex went public in 1994. |
| Who are competitors of Teleflex? | Similar companies to Teleflex include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Teleflex? | Teleflex's current market cap is $5.4B |
| What is the current revenue of Teleflex? | Teleflex's last 12 months revenue is $3.1B. |
| What is the current revenue growth of Teleflex? | Teleflex revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Teleflex? | Current revenue multiple of Teleflex is 2.3x. |
| Is Teleflex profitable? | Yes, Teleflex is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Teleflex? | Teleflex's last 12 months EBITDA is $888M. |
| What is Teleflex's EBITDA margin? | Teleflex's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Teleflex? | Current EBITDA multiple of Teleflex is 8.0x. |
| What is the current FCF of Teleflex? | Teleflex's last 12 months FCF is $455M. |
| What is Teleflex's FCF margin? | Teleflex's last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Teleflex? | Current FCF multiple of Teleflex is 15.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
